
### [MONDO:0016063](http://purl.obolibrary.org/obo/MONDO_0016063)
**Label:** Cowden disease

**Subclasses:** [MONDO:0008021](http://purl.obolibrary.org/obo/MONDO_0008021) (Cowden syndrome 1), 

**Corr. equiv. classes:** [Orphanet:201](http://www.orpha.net/ORDO/Orphanet_201), [Orphanet:65285](http://www.orpha.net/ORDO/Orphanet_65285), [Orphanet:2969](http://www.orpha.net/ORDO/Orphanet_2969), [OMIM:158350](http://purl.obolibrary.org/obo/OMIM_158350), 

**Class expressions from DL-Learner:**

- [HP:0010619](http://purl.obolibrary.org/obo/HP_0010619) (Fibroadenoma of the breast) and [HP:0200036](http://purl.obolibrary.org/obo/HP_0200036) (Skin nodule) 75.00%
- [HP:0010619](http://purl.obolibrary.org/obo/HP_0010619) (Fibroadenoma of the breast) and [HP:0200016](http://purl.obolibrary.org/obo/HP_0200016) (Acrokeratosis) 75.00%
- [HP:0010619](http://purl.obolibrary.org/obo/HP_0010619) (Fibroadenoma of the breast) and [HP:0100568](http://purl.obolibrary.org/obo/HP_0100568) (Neoplasm of the endocrine system) and [HP:0200016](http://purl.obolibrary.org/obo/HP_0200016) (Acrokeratosis) 75.00%
- [HP:0010619](http://purl.obolibrary.org/obo/HP_0010619) (Fibroadenoma of the breast) and [HP:0100031](http://purl.obolibrary.org/obo/HP_0100031) (Neoplasm of the thyroid gland) and [HP:0200016](http://purl.obolibrary.org/obo/HP_0200016) (Acrokeratosis) 75.00%
- [HP:0010619](http://purl.obolibrary.org/obo/HP_0010619) (Fibroadenoma of the breast) and [HP:0040194](http://purl.obolibrary.org/obo/HP_0040194) (Increased head circumference) and [HP:0200036](http://purl.obolibrary.org/obo/HP_0200036) (Skin nodule) 75.00%
- [HP:0010619](http://purl.obolibrary.org/obo/HP_0010619) (Fibroadenoma of the breast) and [HP:0040194](http://purl.obolibrary.org/obo/HP_0040194) (Increased head circumference) and [HP:0200016](http://purl.obolibrary.org/obo/HP_0200016) (Acrokeratosis) 75.00%
- [HP:0010619](http://purl.obolibrary.org/obo/HP_0010619) (Fibroadenoma of the breast) and [HP:0040064](http://purl.obolibrary.org/obo/HP_0040064) (Abnormality of limbs) and [HP:0200016](http://purl.obolibrary.org/obo/HP_0200016) (Acrokeratosis) 75.00%
- [HP:0010619](http://purl.obolibrary.org/obo/HP_0010619) (Fibroadenoma of the breast) and [HP:0030809](http://purl.obolibrary.org/obo/HP_0030809) (Abnormal tongue morphology) and [HP:0200016](http://purl.obolibrary.org/obo/HP_0200016) (Acrokeratosis) 75.00%
- [HP:0010619](http://purl.obolibrary.org/obo/HP_0010619) (Fibroadenoma of the breast) and [HP:0025031](http://purl.obolibrary.org/obo/HP_0025031) (Abnormality of the digestive system) and [HP:0200016](http://purl.obolibrary.org/obo/HP_0200016) (Acrokeratosis) 75.00%
- [HP:0010619](http://purl.obolibrary.org/obo/HP_0010619) (Fibroadenoma of the breast) and [HP:0012639](http://purl.obolibrary.org/obo/HP_0012639) (Abnormality of nervous system morphology) and [HP:0200016](http://purl.obolibrary.org/obo/HP_0200016) (Acrokeratosis) 75.00%
- [HP:0010619](http://purl.obolibrary.org/obo/HP_0010619) (Fibroadenoma of the breast) and [HP:0012638](http://purl.obolibrary.org/obo/HP_0012638) (Abnormality of nervous system physiology) and [HP:0200016](http://purl.obolibrary.org/obo/HP_0200016) (Acrokeratosis) 75.00%
- [HP:0010619](http://purl.obolibrary.org/obo/HP_0010619) (Fibroadenoma of the breast) and [HP:0012243](http://purl.obolibrary.org/obo/HP_0012243) (Abnormal reproductive system morphology) and [HP:0200016](http://purl.obolibrary.org/obo/HP_0200016) (Acrokeratosis) 75.00%
- [HP:0010619](http://purl.obolibrary.org/obo/HP_0010619) (Fibroadenoma of the breast) and [HP:0011842](http://purl.obolibrary.org/obo/HP_0011842) (Abnormality of skeletal morphology) and [HP:0200016](http://purl.obolibrary.org/obo/HP_0200016) (Acrokeratosis) 75.00%
- [HP:0010619](http://purl.obolibrary.org/obo/HP_0010619) (Fibroadenoma of the breast) and [HP:0011772](http://purl.obolibrary.org/obo/HP_0011772) (Abnormality of thyroid morphology) and [HP:0200016](http://purl.obolibrary.org/obo/HP_0200016) (Acrokeratosis) 75.00%
- [HP:0010619](http://purl.obolibrary.org/obo/HP_0010619) (Fibroadenoma of the breast) and [HP:0011368](http://purl.obolibrary.org/obo/HP_0011368) (Epidermal thickening) and [HP:0200036](http://purl.obolibrary.org/obo/HP_0200036) (Skin nodule) 75.00%


